Anavex Life Sciences Corp (AVXL)

[TempePhil]

Abe, the money that was in the bank, was fine for two years of normal trial levels, but there appears to be more than the normal number of trials lining up. Suppose trial counts double, then cash would be enough for only one year. Extra cash would be wise to have, especially if available at a small dilution level.

Getting into 2-73 distribution, for Rett for starters, will require investment in space and people. This will need to be at least started, soon, before the revenue stream is present. Extra cash would be wise to have, especially if available at a small dilution level.

EVENTUALLY revenue will cover all expenses.

Going forward, whenever cash, or loans are needed, having cash in hand puts Ana in a better negotiating (think interest rate, or cost of cantor) position.

I am confident Dr.Missling would agree with one or all of the reasons above.